Gamida Cell Ltd. - Ordinary Shares (GMDA): Price and Financial Metrics
GMDA Price/Volume Stats
Current price | $0.03 | 52-week high | $2.51 |
Prev. close | $0.04 | 52-week low | $0.03 |
Day low | $0.03 | Volume | 23,036,800 |
Day high | $0.04 | Avg. volume | 9,201,723 |
50-day MA | $0.32 | Dividend yield | N/A |
200-day MA | $0.76 | Market Cap | 5.04M |
GMDA Stock Price Chart Interactive Chart >
Gamida Cell Ltd. - Ordinary Shares (GMDA) Company Bio
Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
GMDA Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | -90.10% |
3-year | -98.92% |
5-year | -99.38% |
YTD | -92.73% |
2023 | -68.01% |
2022 | -49.21% |
2021 | -69.73% |
2020 | 95.12% |
2019 | -56.74% |
Loading social stream, please wait...